Despite winning an FDA green light nearly three months ago for its first wearable insulin delivery system, Embecta is now ...

Sequel Med Tech is working to sell a new, more precise type of insulin pump that can measure the amount of insulin delivered to users. CEO Alan Lotvin, former president of pharmacy benefit manager ...

Embecta announced today that it discontinued its insulin patch pump program and plans to initiate a restructuring plan.

Forgetting to inject insulin before meals can be a problem that contributes to long-term complications from diabetes, which is why Medtronic designed a system that it says is the first to recommend ...

CEO Dev Kurdikar said the decision may “come as a surprise” as Embecta just received FDA clearance for a patch pump, but the company “did not intend to do a full market launch of this product.” ...

The clearance paves the way for the launch of Medtronic’s Smart MDI system, which combines its InPen and Simplera continuous ...

So I found a new doctor, who told me to start testing my blood glucose ... Perhaps the most powerful aspect of CGM readings ...

With a new smartphone app clearance from the FDA, Medtronic said it has all the pieces necessary to deliver a complete ...

Kurdikar, CEO of Embecta (EMBC) said, “As our stand-up work nears completion and following an in-depth review of our portfolio ...